Search Count: 22
 |
The Hiv Protease Inhibitor Amprenavir Binding To The Active Site Of Cryphonectria Parasitica Endothiapepsin
Organism: Cryphonectria parasitica
Method: X-RAY DIFFRACTION Resolution:1.80 Å Release Date: 2024-07-10 Classification: HYDROLASE Ligands: 478, PG4, PGE, EDO, ACY |
Organism: Cryphonectria parasitica
Method: X-RAY DIFFRACTION
Release Date: 2024-07-10
Ligands: 478, PG4, PGE, EDO, ACY
 |
Crystal Structure Of Hiv-1 Protease Multiple Mutants Prs17 With Revertant Mutation V48G Bound To Inhibitor Amprenavir
Organism: Human immunodeficiency virus type 1 group m subtype b (isolate bru/lai)
Method: X-RAY DIFFRACTION Resolution:1.39 Å Release Date: 2021-09-08 Classification: HYDROLASE Ligands: 478, GOL |
Organism: Human immunodeficiency virus type 1 group m subtype b (isolate bru/lai)
Method: X-RAY DIFFRACTION
Release Date: 2021-09-08
Ligands: 478, GOL
 |
Crystal Structure Of Hiv-1 Protease Multiple Mutants Prs17 Bound To Inhibitor Amprenavir
Organism: Human immunodeficiency virus type 1 group m subtype b (isolate bru/lai)
Method: X-RAY DIFFRACTION Resolution:1.47 Å Release Date: 2021-09-08 Classification: HYDROLASE Ligands: 478 |
Organism: Human immunodeficiency virus type 1 group m subtype b (isolate bru/lai)
Method: X-RAY DIFFRACTION
Release Date: 2021-09-08
Ligands: 478
 |
Porcine Pepsin In Complex With Amprenavir
Organism: Sus scrofa
Method: X-RAY DIFFRACTION Resolution:1.99 Å Release Date: 2021-06-16 Classification: HYDROLASE/INHIBITOR Ligands: 478 |
Organism: Sus scrofa
Method: X-RAY DIFFRACTION
Release Date: 2021-06-16
Ligands: 478
 |
Hiv-1 Protease Multiple Drug Resistant Mutant Prs5B With Amprenavir
Organism: Human immunodeficiency virus type 1 group m subtype b (isolate bru/lai)
Method: X-RAY DIFFRACTION Resolution:1.75 Å Release Date: 2020-04-15 Classification: Hydrolase/Hydrolase Inhibitor, Viral Protein Ligands: 478, PO4 |
Organism: Human immunodeficiency virus type 1 group m subtype b (isolate bru/lai)
Method: X-RAY DIFFRACTION
Release Date: 2020-04-15
Ligands: 478, PO4
 |
Joint X-Ray/Neutron Structure Of Hiv-1 Protease Triple Mutant (V32I,I47V,V82I) With Amprenavir At Ph 6.0
Organism: Human immunodeficiency virus 1
Method: NEUTRON DIFFRACTION, X-RAY DIFFRACTION Resolution:1.85 Å, 2.20 Å Release Date: 2017-03-01 Classification: HYDROLASE/HYDROLASE INHIBITOR Ligands: 478, DOD |
Organism: Human immunodeficiency virus 1
Method: NEUTRON DIFFRACTION, X-RAY DIFFRACTION
Release Date: 2017-03-01
Ligands: 478, DOD
 |
Protease E35D-Apv
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION Resolution:1.80 Å Release Date: 2016-09-21 Classification: HYDROLASE/HYDROLASE INHIBITOR Ligands: 478, GOL |
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION
Release Date: 2016-09-21
Ligands: 478, GOL
 |
Crystal Structure Of Multidrug-Resistant Clinical Isolate A02 Hiv-1 Protease In Complex With Amprenavir
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION Resolution:1.60 Å Release Date: 2016-05-04 Classification: hydrolase/hydrolase inhibitor Ligands: 478 |
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION
Release Date: 2016-05-04
Ligands: 478
 |
Joint Neutron And X-Ray Structure Of Per-Deuterated Hiv-1 Protease In Complex With Clinical Inhibitor Amprenavir
Organism: Human immunodeficiency virus type 1
Method: NEUTRON DIFFRACTION, X-RAY DIFFRACTION Resolution:2.01 Å, 2.00 Å Release Date: 2013-07-24 Classification: HYDROLASE/HYDROLASE INHIBITOR Ligands: CL, 478, DOD |
Organism: Human immunodeficiency virus type 1
Method: NEUTRON DIFFRACTION, X-RAY DIFFRACTION
Release Date: 2013-07-24
Ligands: CL, 478, DOD
 |
Crystal Structure Of Multidrug Resistant Hiv-1 Protease Clinical Isolate Pr20 In Complex With Amprenavir
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION Resolution:1.80 Å Release Date: 2013-05-15 Classification: HYDROLASE/HYDROLASE INHIBITOR Ligands: CL, 478 |
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION
Release Date: 2013-05-15
Ligands: CL, 478
 |
Hiv-1 Protease Triple Mutants V32I, I47V, V82I With Antiviral Drug Amprenavir
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION Resolution:1.26 Å Release Date: 2012-03-21 Classification: HYDROLASE/HYDROLASE INHIBITOR Ligands: 478, IOD, GOL |
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION
Release Date: 2012-03-21
Ligands: 478, IOD, GOL
 |
The Crystal Structure Of Xmrv Protease Complexed With Amprenavir
Organism: Dg-75 murine leukemia virus
Method: X-RAY DIFFRACTION Resolution:1.75 Å Release Date: 2011-10-12 Classification: hydrolase/hydrolase inhibitor Ligands: 478 |
Organism: Dg-75 murine leukemia virus
Method: X-RAY DIFFRACTION
Release Date: 2011-10-12
Ligands: 478
 |
Crystal Structure Of Hiv-1 I50V, A71 Protease In Complex With The Protease Inhibitor Amprenavir.
Organism: Hiv-1 m:b_arv2/sf2
Method: X-RAY DIFFRACTION Resolution:1.75 Å Release Date: 2011-09-28 Classification: Hydrolase/Hydrolase Inhibitor Ligands: 478, PO4, GOL, ACT, SO4 |
Organism: Hiv-1 m:b_arv2/sf2
Method: X-RAY DIFFRACTION
Release Date: 2011-09-28
Ligands: 478, PO4, GOL, ACT, SO4
 |
Crystal Structure Of Hiv-1 Protease Mutant I54M With Antiviral Drug Amprenavir
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION Resolution:1.16 Å Release Date: 2010-08-25 Classification: HYDROLASE/HYDROLASE INHIBITOR Ligands: CL, NA, ACT, 478 |
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION
Release Date: 2010-08-25
Ligands: CL, NA, ACT, 478
 |
Crystal Structure Of Hiv-1 Protease Mutant I84V With Antiviral Drug Amprenavir
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION Resolution:1.85 Å Release Date: 2010-08-25 Classification: HYDROLASE/HYDROLASE INHIBITOR Ligands: 478, IOD |
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION
Release Date: 2010-08-25
Ligands: 478, IOD
 |
Crystal Structure Of Hiv-1 Protease Mutant I54V With Antiviral Drug Amprenavir
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION Resolution:1.50 Å Release Date: 2010-08-25 Classification: HYDROLASE/HYDROLASE INHIBITOR Ligands: IOD, 478 |
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION
Release Date: 2010-08-25
Ligands: IOD, 478
 |
Crystal Structure Of Hiv-1 Protease Mutant L90M With Antiviral Drug Amprenavir
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION Resolution:1.35 Å Release Date: 2010-08-25 Classification: HYDROLASE/HYDROLASE INHIBITOR Ligands: IOD, 478 |
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION
Release Date: 2010-08-25
Ligands: IOD, 478
 |
Crystal Structure Of The Inhibitor Amprenavir (Apv) In Complex With A Multi-Drug Resistant Hiv-1 Protease Variant (L10I/G48V/I54V/V64I/V82A)Refer: Flap+ In Citation
Organism: Hiv-1 m:b_arv2/sf2
Method: X-RAY DIFFRACTION Resolution:2.15 Å Release Date: 2009-09-01 Classification: HYDROLASE Ligands: PO4, ACT, 478 |
Organism: Hiv-1 m:b_arv2/sf2
Method: X-RAY DIFFRACTION
Release Date: 2009-09-01
Ligands: PO4, ACT, 478
 |
Crystal Structure Of The Wild Type Hiv-1 Protease With The Inhibitor, Amprenavir
Organism: Hiv-1 m:b_arv2/sf2
Method: X-RAY DIFFRACTION Resolution:1.75 Å Release Date: 2009-09-01 Classification: HYDROLASE Ligands: 478, ACT |
Organism: Hiv-1 m:b_arv2/sf2
Method: X-RAY DIFFRACTION
Release Date: 2009-09-01
Ligands: 478, ACT
 |
Crystal Structure Of Amprenavir (Apv) In Complex With A Drug Resistant Hiv-1 Protease Variant (I50L/A71V).
Organism: Hiv-1 m:b_arv2/sf2
Method: X-RAY DIFFRACTION Resolution:2.20 Å Release Date: 2009-09-01 Classification: HYDROLASE Ligands: ACT, 478 |
Organism: Hiv-1 m:b_arv2/sf2
Method: X-RAY DIFFRACTION
Release Date: 2009-09-01
Ligands: ACT, 478